OKYO Pharma (OKYO) Debt Ratio (2022 - 2025)

OKYO Pharma (OKYO) has reported Debt Ratio for 4 consecutive years, with 0.09 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Debt Ratio fell 42.92% year-over-year to 0.09 in Q3 2025; TTM through Sep 2025 was 0.09, a 42.92% decrease from a year earlier, with the FY2025 full-year figure at 0.23, changed 0.41% from the prior year.
• Debt Ratio was 0.09 for Q3 2025 at OKYO Pharma, down from 0.23 in the prior quarter.
• Over five years, Debt Ratio peaked at 10938.26 in Q1 2022 and troughed at 0.09 in Q3 2025.
• A 4-year average of 1562.76 and a median of 0.22 in 2023 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio sank 100.0% in 2023 and soared 55.44% in 2024, its largest moves.
• Over 4 years, Debt Ratio stood at 10938.26 in 2022, then plunged by 100.0% to 0.22 in 2023, then decreased by 27.49% to 0.16 in 2024, then tumbled by 42.92% to 0.09 in 2025.
• The last three Debt Ratio figures came in at 0.09 (Q3 2025), 0.23 (Q1 2025), and 0.16 (Q3 2024), per Business Quant data.